Drug Shortage Report for KADIAN

Last updated on 2017-04-12 History
Report ID 3704
Drug Identification Number 02184435
Brand name KADIAN
Common or Proper name Kadian
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) MORPHINE SULFATE
Strength(s) 20MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL
Packaging size 100s
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2017-04-11
Actual start date
Estimated end date
Actual end date 2017-04-11
Shortage status Resolved
Updated date 2017-04-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2017-04-12 French Compare
v8 2017-04-12 English Compare
v7 2017-04-12 French Compare
v6 2017-04-12 English Compare
v5 2017-04-12 English Compare
v4 2017-04-12 English Compare
v3 2017-04-12 English Compare
v2 2017-03-20 French Compare
v1 2017-03-20 English Compare

Showing 1 to 9 of 9